Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cadila Pharmaceuticals Ltd.
DescriptionPolypill containing thiazide, atenolol, ramipril, simvastatin and aspirin
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase II
Standard Indication Cardiovascular (unspecified)
Indication DetailsReduce risk factors for cardiovascular disease (CVD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today